TheProfitWatch

ATRA - Atara Biotherapeutics, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
15.02 0.1 (0.63%) --- --- --- 0.0 (0.0%) 0.03 (0.17%) --- 0.0 (0.0%)

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
0.2
Diluted EPS:
0.19
Basic P/E:
75.575
Diluted P/E:
79.5526
RSI(14) 1m:
30.77
VWAP:
15.21
RVol:
0.4647

Events

Period Kind Movement Occurred At
1m Price decrease 1m 14.61 -0.48 (-3.18%) Oct 15 09:30
10m Price decrease 10m 14.61 -0.48 (-3.18%) Oct 15 09:30

Related News